Can Handwriting and EEG Help Spot Alzheimer's Disease Earlier? A Small Pilot Tests It
A completed 20-person pilot at the University of Évora tests whether handwriting kinematics and brain EEG rhythms can support early Alzheimer's identification.
Summary
Alzheimer's disease affects thinking and fine motor control, and both show up in handwriting. Speed, movement time and stroke patterns can change at different stages of the disease. Brain electrical activity measured with EEG may also reflect early brain dysfunction. This small registered study at the University of Évora, with 20 participants, set out to test whether a handwriting assessment protocol is suitable for helping identify people with Alzheimer's disease. It is a feasibility and protocol-suitability study, not a treatment trial. The registry entry lists the study as completed but the abstract reports no results, so we do not yet know how well handwriting or EEG separated people with Alzheimer's from others. The idea is appealing because handwriting tasks are cheap, quick and noninvasive. If validated in larger studies, they could become a practical screening aid. For now, this is a design and rationale, not evidence of diagnostic accuracy.
Detailed Summary
Why this matters: Alzheimer's disease is the most common cause of dementia, and the brain changes behind it begin years before obvious memory loss. Tools that detect early change cheaply and noninvasively could help people and clinicians act sooner on lifestyle, risk-factor and treatment decisions that matter for healthspan.
What was studied: This registered study from the University of Évora, listed as completed with 20 participants, examined whether a handwriting assessment protocol is suitable for supporting the identification of people with Alzheimer's disease. Handwriting depends on many brain regions and combines fine motor control with executive function. Sensorimotor decline can appear as changes in movement time, speed and movement profiles. The protocol is also framed alongside EEG, which records brain electrical rhythms and may reflect early brain dysfunction, although the abstract notes that EEG measures lack validation across healthy and non-healthy populations.
Key results: No results are reported in the available abstract. The registry states the study was completed between December 2023 and July 2024, but it gives no accuracy figures, effect sizes or group comparisons. We cannot say whether handwriting kinematics or EEG distinguished participants with Alzheimer's disease from others. The abstract also reports no harms, since the work appears to be observational and noninvasive.
Implications: The concept is plausible: handwriting kinematics are a functional readout of motor and cognitive circuits, and EEG offers a direct measure of brain activity. If validated, such measures could complement cognitive tests and blood or imaging biomarkers as accessible screening tools. At this point, the contribution is a feasibility protocol that could inform larger studies.
Caveats: This summary is based on the registry abstract only. With 20 participants and no reported outcomes, the study cannot establish diagnostic accuracy. Handwriting is influenced by education, age, handedness and other conditions, so larger, well-controlled validation work is needed before any clinical use.
Key Findings
- Registered study of 20 participants tests a handwriting assessment protocol to support identification of Alzheimer's disease.
- Handwriting kinematics such as movement time, speed and profiles are proposed markers of sensorimotor decline in Alzheimer's.
- EEG brain rhythms are proposed as an early indicator of brain dysfunction but lack validation across populations.
- No results, accuracy data or harms are reported; the study is listed as completed (2023-2024).
Methodology
This is a registered clinical study sponsored by the University of Évora with 20 enrolled participants, completed in July 2024. The abstract describes a protocol-suitability assessment combining handwriting tasks and EEG measures. Design details, comparison groups and endpoints are not given in the abstract.
Study Limitations
This summary is based on the abstract only, and no results are reported. The sample of 20 is small, and the design, controls and endpoints are unclear. Diagnostic accuracy, reproducibility and confounders such as education and motor conditions remain untested here.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
